Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Free Cash Flow Generation Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Free Cash Flow Generation Index of 0.84x as of September 2025. Free cash flow of CN¥192.09 Million represents 1% of operating cash flow (CN¥227.64 Million). Explore how much does Zhejiang Jingxin Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see how efficiently does Zhejiang Jingxin Pharmaceutical Co Ltd generate cash.
Annual Free Cash Flow Generation for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jingxin Pharmaceutical Co Ltd. Check Zhejiang Jingxin Pharmaceutical Co Ltd (002020) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | CN¥578.50 Million | CN¥781.35 Million | CN¥202.85 Million | ▲ +13.1% |
| 2024 | 0.65x | CN¥475.52 Million | CN¥726.16 Million | CN¥250.65 Million | ▲ +97.6% |
| 2023 | 0.33x | CN¥273.32 Million | CN¥824.69 Million | CN¥519.51 Million | ▼ -16.6% |
| 2022 | 0.40x | CN¥340.20 Million | CN¥855.78 Million | CN¥515.57 Million | ▲ +468.2% |
| 2021 | -0.11x | CN¥-39.41 Million | CN¥365.02 Million | CN¥404.43 Million | ▼ -130.9% |
| 2020 | 0.35x | CN¥179.21 Million | CN¥513.21 Million | CN¥334.00 Million | ▼ -5.6% |
| 2019 | 0.37x | CN¥197.97 Million | CN¥535.30 Million | CN¥337.33 Million | ▼ -31.2% |
| 2018 | 0.54x | CN¥281.21 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -24.2% |
| 2017 | 0.71x | CN¥272.82 Million | CN¥385.01 Million | CN¥112.19 Million | ▲ +13.7% |
| 2016 | 0.62x | CN¥157.43 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +196.7% |
| 2015 | 0.21x | CN¥30.39 Million | CN¥144.69 Million | CN¥114.31 Million | ▼ -61.8% |
| 2014 | 0.55x | CN¥115.74 Million | CN¥210.49 Million | CN¥94.75 Million | ▲ +2117.5% |
| 2013 | 0.02x | CN¥2.75 Million | CN¥111.03 Million | CN¥108.28 Million | ▲ +106.4% |
| 2012 | -0.39x | CN¥-23.23 Million | CN¥60.28 Million | CN¥83.51 Million | ▼ -993.9% |
| 2011 | -0.04x | CN¥-2.45 Million | CN¥69.41 Million | CN¥71.86 Million | ▲ +97.8% |
| 2010 | -1.62x | CN¥-96.32 Million | CN¥59.55 Million | CN¥155.87 Million | ▼ -290.1% |
| 2009 | 0.85x | CN¥115.20 Million | CN¥135.38 Million | CN¥20.18 Million | ▲ +284.5% |
| 2008 | -0.46x | CN¥-13.83 Million | CN¥29.98 Million | CN¥43.81 Million | ▲ +60.9% |
| 2005 | -1.18x | CN¥-72.85 Million | CN¥61.82 Million | CN¥134.67 Million | ▲ +91.7% |
| 2004 | -14.26x | CN¥-91.68 Million | CN¥6.43 Million | CN¥98.11 Million | ▼ -2531.7% |
| 2003 | -0.54x | CN¥-25.01 Million | CN¥46.18 Million | CN¥71.19 Million | ▼ -973.6% |
| 2002 | -0.05x | CN¥-2.30 Million | CN¥45.50 Million | CN¥47.79 Million | — |